Skip to main content

Advertisement

SpringerLink
Log in

Mechanisms and evidence for the role of enhanced external counterpulsation in heart failure management

  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Balloon counterpulsation has gained widespread acceptance as a therapy for cardiogenic shock. However, over the past four decades a parallel method of noninvasive counterpulsation, enhanced external counterpulsation (EECP), has been defined and developed. Mechanisms of benefit for this technology continue to emerge and include enhanced coronary and other key target organ perfusion beds. Other mechanisms include angiogenesis and enhanced cellular metabolism. Beyond putative mechanisms there is ample evidence for improved and sustained outcomes in patients with and without left ventricular dysfunction. This evidence comes from long-term registry reports and randomized clinical trials. With respect to heart failure (HF), there is registry, pilot trial, and randomized clinical trial evidence of safety and efficacy. This paper summarizes some of the mechanisms and outcomes of EECP in HF patients and helps to elucidate the role of EECP in the management of patients with chronic HF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Beckman CB, Romero LH, Shatney CH, et al.: Clinical comparison of the intra-aortic balloon pump and external counterpulsation for cardiogenic shock. Trans Am Soc Artif Intern Organs 1973, 19:414–418.

    PubMed  CAS  Google Scholar 

  2. Amsterdam EA, Banas J, Criley JM, et al.: Clinical assessment of external pressure circulatory assistance in acute myocardial infarction. Report of a cooperative clinical trial. Am J Cardiol 1980, 45:349–356.

    Article  PubMed  CAS  Google Scholar 

  3. Michaels AD, Accad M, Ports TA, Grossman W: Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation. Circulation 2002, 106:1237–1242. This study evaluated 10 patients administered EECP while undergoing diagnostic cardiac catheterization using intracoronary pressure and flow wires and angiographic techniques to assess acute effects. Dramatic increases were seen in diastolic (+ 93%) and mean intracoronary (+ 16%) pressures along with a decrease in systolic pressure (-15%). Average intracoronary peak velocity significantly increased (+ 109%) by Doppler measurement and flow significantly increased (+ 28%) by TIMI frame count. Increases in coronary perfusion together with systolic unloading demonstrate the mechanical assist properties of EECP.

    Article  PubMed  Google Scholar 

  4. Solignac A, Ferguson RJ, Bourassa MG: External counterpulsation: coronary hemodynamics and use in treatment of patients with stable angina pectoris. Cathet Cardiovasc Diagn 1977, 3:37–45.

    Article  PubMed  CAS  Google Scholar 

  5. Arora RR, Chou TM, Jain D, et al.: The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol 1999, 33:1833–1840.

    Article  PubMed  CAS  Google Scholar 

  6. Michaels AD, Linnemeier G, Soran O, et al.: Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International Patient Registry [IEPR]). Am J Cardiol 2004, 93:461–464.

    Article  PubMed  Google Scholar 

  7. Arora RR, Chou TM, Jain D, et al.: Effects of enhanced external counterpulsation on health-related quality of life continue 12 months after treatment: a substudy of the Multicenter Study of Enhanced External Counterpulsation. J Investig Med 2002, 50:25–32.

    PubMed  Google Scholar 

  8. Vasomedical, Inc. http://www.vasomedical.com. Data on file.

  9. Taguchi I, Ogawa K, Oida A, et al.: Comparison of hemodynamic effects of enhanced external counterpulsation and intra-aortic balloon pumping in patients with acute myocardial infarction. Am J Cardiol 2000, 86:1139–1141. This study compared hemodynamic effects of EECP with those of IABP in 39 acute myocardial infarction patients. Although initially increased, right atrial and pulmonary capillary wedge pressures were unchanged with IABP, then gradually decreased with EECP. EECP, but not IABP, increased cardiac index signi ficantly. Both techniques increased diastolic pressures and decreased systolic pressures and systemic vascular resistance. No adverse events were seen with EECP early after acute myocardial infarction and cardiac catheterization.

    Article  PubMed  CAS  Google Scholar 

  10. Taguchi I, Ogawa K, Kanaya T, et al.: Effects of enhanced external counterpulsation on hemodynamics and its mechanism. Circulation 2004, 68:1030–1034.

    Article  Google Scholar 

  11. Werner D, Michalk F, Harazny J, et al.: Accelerated reperfusion of poorly perfused retinal areas in central retinal artery occlusion and branch retinal artery occlusion after a short treatment with enhanced external counterpulsation. Retina 2004, 24:541–547.

    Article  PubMed  Google Scholar 

  12. Applebaum RM, Kasliwal R, Tunik PA, et al.: Sequential external counterpulsation increases cerebral and renal blood flow. Am Heart J 1997, 133:611–615.

    Article  PubMed  CAS  Google Scholar 

  13. Hilz MJ, Werner D, Marthol H, et al.: Enhanced external counterpulsation improves skin oxygenation and perfusion. Eur J Clin Invest 2004, 34:385–391.

    Article  PubMed  CAS  Google Scholar 

  14. Werner D, Trägner P, Wawer A, et al.: Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis. Nephrol Dial Transplant 2005, 20:920–926.

    Article  PubMed  Google Scholar 

  15. Wu G, Du Z, Hu C, Zheng Z, et al.: Angiogenic effects of long-term enhanced external counterpulsation in a dog model of myocardial infarction. Am J Physiol Heart Circ Physiol 2006, 290:248–254.

    Article  CAS  Google Scholar 

  16. Jacobey JA, Taylor WJ, Smith GT, et al.: A new therapeutic approach to acute coronary occlusion. Am J Cardiol 1963, 11:218–227.

    Article  Google Scholar 

  17. Kho S, Liuzzo J, Suresh K, et al.: Vascular endothelial growth factor and atrial natriuretic peptide in enhanced counterpulsation [abstract 561]. Abstract presented at the 82nd Annual Meeting of the Endocrine Society. Toronto, Ontario, Canada; June 21–24, 2000.

  18. Masuda D, Nohara R, Kataoka K, et al.: Enhanced external counterpulsation promotes angiogenesis factors in patients with chronic stable angina. Circulation 2001, 104(17 Suppl II):444.

    Google Scholar 

  19. Werner D, Michelson G, Harazny J, et al.: Changes in ocular blood flow velocities during external counterpulsation in healthy volunteers and patients with atherosclerosis. Graefes Arch Clin Exp Ophthalmol 2001, 239:599–602.

    PubMed  CAS  Google Scholar 

  20. Bonetti PO, Barsness GW, Keelan PC, et al.: Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003, 41:1761–1768. Endothelial function was assessed in 23 patients using an index of reactive hyperemia response. EECP acutely improved endothelial function immediately after a course of treatment and 1 month later. Persistence of improved endothelial function was associated with clinical improvement.

    Article  PubMed  Google Scholar 

  21. Nichols WW, Braith RW, Aggarwal R, et al.: Enhanced external counterpulsation decreases wave refiection amplitude and reduces left ventricular afterload and systolic stress in patients with refractory angina [abstract]. J Am Coll Cardiol 2004, 43(5 Suppl A):307A.

    Article  Google Scholar 

  22. Urano H, Ikeda H, Ueno T, et al.: Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol 2001, 37:93–99.

    Article  PubMed  CAS  Google Scholar 

  23. Masuda D, Nohara R, Hirai T, et al.: Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by 13N-ammonia positron emission tomography. Eur Heart J 2001, 16:1451–1458.

    Article  Google Scholar 

  24. Tartaglia J, Stenerson J Jr, Charney R, et al.: Exercise capability and myocardial perfusion in chronic angina patients treated with enhanced external counterpulsation. Clin Cardiol 2003, 26:287–290.

    PubMed  CAS  Google Scholar 

  25. Stys TP, Lawson WE, Hui JC, et al.: Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am J Cardiol 2002, 89:822–824.

    Article  PubMed  Google Scholar 

  26. Michaels AD, Raisinghani A, Soran O, et al.: The effects of enhanced external counterpulsation on myocardial perfusion in patients with stable angina: a single blind multicenter pilot study [abstract]. J Am Coll Cardiol 2004, 43(5 Suppl A):308A.

    Article  Google Scholar 

  27. Bonetti PO, Gadasalli SN, Lerman A, et al.: Successful treatment of symptomatic coronary endothelial dysfunction with enhanced external counterpulsation. Mayo Clin Proc 2004, 79:690–692.

    Article  PubMed  Google Scholar 

  28. Wu GF, Qiang SZ, Zheng ZS, et al.: A neurohormonal mechanism for the effectiveness of enhanced external counterpulsation [abstract]. Circulation 1999, 100:I-832.

    Google Scholar 

  29. Qian X, Wu W, Zheng ZS, et al.: Effect of enhanced external counterpulsation on nitric oxide production in coronary disease [abstract]. J Heart Dis 1999, 1:193.

    Google Scholar 

  30. Levenson J, Pernollet MG, Iliou MC, et al.: Enhanced external counterpulsation acutely increases blood and platelet cGMP [abstract]. Circulation 2003, 108(17 Suppl IV):589.

    Google Scholar 

  31. Masuda D, Fujita M, Nohara R, et al.: Improvement of oxygen metabolism in ischemic myocardium as a result of enhanced external counterpulsation with heparin pretreatment for patients with stable angina. Heart Vessels 2004, 19:59–62.

    Article  PubMed  Google Scholar 

  32. Gorscan J III, Crawford L, Soran O, et al.: Improvement in left ventricular performance by enhanced external counterpulsation in patients with heart failure [abstract]. J Am Coll Cardiol 2000, 35(2 Suppl A):203A.

    Google Scholar 

  33. Grayson D, de Jong A, Ochoa A, et al.: Oxygen consumption changes during EECP treatment in patients with and without coronary artery disease. Med Sci Sports Exerc, 2004, 36(Suppl):S214.

    Google Scholar 

  34. Lawson WE, Silver MA, Kennard L, et al.: Angina patients with diastolic or systolic heart failure demonstrate comparable immediate and one year benefit from enhanced external counterpulsation. J Card Fail 2003, 9:S107.

    Article  Google Scholar 

  35. Soran O, Kennard ED, Kelsey S, et al.: Enhanced external counterpulsation as treatment for chronic angina in patients with left ventricular dysfunction: a report from the International EECP Patient Registry (IEPR). Congest Heart Fail 2002, 6:297–302, 312.

    Google Scholar 

  36. Soran O, Kennard ED, Kfoury B, et al.: Two year clinical outcomes, after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction. (Report from the International EECP Patient Registry (IEPR). Am J Cardiol 2006, 97:17–20. A 2-year, prospective, cohort study assessing clinical outcomes in 363 patients with severe LVD undergoing EECP therapy for angina. Seventy-two percent improved from severe to no or mild angina. Fifty-two percent discontinued nitroglycerin use and quality of life improved substantially when assessed immediately after EECP. The reduction in angina benefit was sustained in 55% at two years. Two-year survival was 83%, and the major adverse cardiovascular event-free survival rate was 70%.

    Article  PubMed  Google Scholar 

  37. Soran O, Fleishman B, Demarco T, et al.: Enhanced external counterpulsation in patients with heart failure: a multicenter feasibility study. Congest Heart Fail 2002, 8:204–208, 227. A prospective, 6-month follow-up feasibility study of EECP in 26 patients with chronic stable NYHA Class II/III HF, LVEF ≤ 35%, on optimal pharmacologic therapy. No clinically siginificant adverse events occurred during the study. Significant improvements were seen in exercise capacity (peak oxygen uptake and exercise duration) and in quality of life at 1 week and 6 months after completion of EECP. This study led to the initiation of a randomized, controlled clinical trial of EECP in HF (PEECH).

    PubMed  Google Scholar 

  38. Feldman AM, Silver AM, Francis GS, et al.: Treating heart failure with enhanced external counterpulsation (EECP): design of the Prospective Evaluation of EECP in Heart Failure (PEECH) trial. J Card Fail 2005, 11:240–245. Critical design issues relating to the randomized study of EECP therapy in patients with chronic stable HF are explained. Numerous aspects pertain to clinical trials of medical devices.

    Article  PubMed  Google Scholar 

  39. Arora RR, Lopez S, Saric M: Enhanced external counterpulsation improves systolic function by echocardiography in patients with coronary artery disease. Heart Lung 2005, 34:122–125.

    Article  PubMed  Google Scholar 

  40. Linnemeier GC, Kennard ED, Soran O, et al.: Enhanced external counterpulsation improves functional capacity in patients with left ventricular dysfunction as assessed by the Duke Activity Status Index - a questionnaire correlated with peak oxygen uptake. J Card Fail 2003, 9(5 Suppl):S107.

    Article  Google Scholar 

  41. Lawson WE, Silver MA, Hui JC, et al.: Angina patients with diastolic versus systolic heart failure demonstrate comparable immediate and one-year benefit from enhanced external counterpulsation. J Card Fail 2005, 11:61–66. A prospective cohort study in patients with evidence of systolic or diastolic dysfunction undergoing EECP therapy for angina. Clinical and quality-of-life improvements were Significant compared with baseline and similar regardless of etiology.

    Article  PubMed  Google Scholar 

  42. Henrickson CA, Chandra-Strobos N: Enhanced external counterpulsation therapy: significant clinical improvement without electrophysiologic remodeling. Ann Noninvasive Electrocardiol 2004, 9:265–269.

    Article  Google Scholar 

  43. Stein PK, Domitrovich PP, Huikuri HV, et al.: Traditional and nonlinear heart rate variability are each independently associated with mortality after myocardial infarction. J Cardiovasc Electrophysiol 2005, 16:13–20.

    Article  PubMed  Google Scholar 

  44. Lawson WE, Kennard ED, Holubkov R, et al.: Benefit and safety of enhanced external counterpulsation in treating coronar y arter y disease patients with a histor y of congestive heart failure. Cardiology 2001, 96:78–84.

    Article  PubMed  CAS  Google Scholar 

  45. Lawson WE, Hui JC, Kennard ED, et al.: Benefit and safety of enhanced external counterpulsation in the treatment of ischemic heart disease with histor y of congestive heart failure. J Card Fail 2000, 6:84.

    Google Scholar 

  46. Linnemeier G, Michaels AD, Soran O, et al.: Enhanced external counterpulsation in the management of angina in the elderly. Am J Geriatr Cardiol 2003, 12:90–96.

    Article  PubMed  Google Scholar 

  47. Soran O, Kennard ED, Kelsey SF, et al.: Enhanced external counterpulsation as treatment for chronic angina in patients with left ventricular dysfunction: a report from the International EECP Patient Registr y (IEPR). Congest Heart Fail 2002, 8:297–302.

    PubMed  Google Scholar 

  48. Linnemeier G, Rutter MK, Barsness G, et al.: Enhanced external counterpulsation for the relief of angina in patients with diabetes: safety, efficacy and 1-year clinical outcomes. Am Heart J 2003, 146:453–458.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Advocate Christ Medical Center, 4440 West 95th Street Suite 319 South, 60453, Oak Lawn, IL, USA

    Marc A. Silver MD

Authors
  1. Marc A. Silver MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marc A. Silver MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Silver, M.A. Mechanisms and evidence for the role of enhanced external counterpulsation in heart failure management. Curr Heart Fail Rep 3, 25–32 (2006). https://doi.org/10.1007/s11897-006-0028-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-006-0028-4

Keywords

Search

Navigation